| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |